Product Information
HISTEX-DM SYRUP is a generic product labeled by Allegis Pharmaceuticals, LLC, priced at $0.0749 per ML under NDC 28595080416. Its NADAC has been published 142 times since Jan 17, 2018.
HISTEX-DM SYRUP
DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDEStrength
20; 10; 2.5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Allegis Pharmaceuticals, LLCNDC
28595080416
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/19/2014
Pharmacological Classes
Price Statistics
The NADAC for HISTEX-DM SYRUP has been published 142 times since Jan 17, 2018, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0749 per ML |
|---|---|
| All-time high | $0.0749 (Sep 30, 2026) |
| All-time low | $0.0703 (Jan 17, 2018) |
| 52-week high | $0.0749 |
| 52-week low | $0.0712 |
| Median price | $0.0712 |
| Average price | $0.0713 |
| Largest weekly change | +3.4% (May 20, 2026) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allegis Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, and TRIPROLIDINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HISTEX-DM SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for HISTEX-DM SYRUP, manufactured by Allegis Pharmaceuticals, LLC, is $0.0749 per ML (NDC 28595080416), effective Sep 30, 2026.
How has the price of HISTEX-DM SYRUP changed over time?
Over the history we have for it, the NADAC for HISTEX-DM SYRUP has risen 6.6%. It has been tracked across 142 weekly CMS publications since Jan 17, 2018.
What are the highest and lowest recorded NADAC prices for HISTEX-DM SYRUP?
Since Jan 17, 2018, the NADAC for HISTEX-DM SYRUP has ranged from a low of $0.0703 (Jan 17, 2018) to a high of $0.0749 (Sep 30, 2026), with a median of $0.0712 per ML.
Are there cheaper alternatives to HISTEX-DM SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of HISTEX-DM SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HISTEX-DM SYRUP?
HISTEX-DM SYRUP (NDC 28595080416) is labeled by Allegis Pharmaceuticals, LLC, and CMS classifies it as a generic product.